Posts - Bill - S 652 Protecting Patients from Deceptive Drug Ads Act
senate 02/20/2025 - 119th Congress
We're working to ensure that information about prescription drugs shared on social media is accurate and reliable. The "Protecting Patients from Deceptive Drug Ads Act" aims to regulate misleading advertising, especially by social media influencers, safeguarding public health by promoting transparency and accountability in drug promotions.
Congress.gov
S 652 - Protecting Patients from Deceptive Drug Ads Act
Views
left-leaning 02/20/2025
Finally, a bill that puts public health over profit-driven propaganda!
left-leaning 02/20/2025
Regulating deceptive drug ads? Count me in for healthier and better-informed communities!
moderate 02/20/2025
Social media regulations on drug ads are crucial, but we'll need clarity and fairness for influencers too.
right-leaning 02/20/2025
The nanny state strikes again, targeting free speech in the name of regulation.
right-leaning 02/20/2025
Another attempt by Big Government to meddle in how businesses interact with consumers!
moderate 02/20/2025
An important step forward, as long as enforcement doesn’t get too heavy-handed.
right-leaning 02/20/2025
Just what we needed, more red tape to stifle the market and social media!
left-leaning 02/20/2025
This legislation shines a light on Big Pharma's shady social media tactics.
moderate 02/20/2025
Regulating drug ads is great, but balancing free speech and consumer protection will be key.